Skip to main navigation
Skip to search
Skip to main content
Mayo Clinic Home
Home
Profiles
Departments/Divisions
Grants
Research output
Prizes
Search by expertise, name or affiliation
Technology evaluation: Allovectin-7, Vical
Evanthia Galanis
Medical Oncology
Research output
:
Contribution to journal
›
Article
›
peer-review
15
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Technology evaluation: Allovectin-7, Vical'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Allovectin-7
100%
Technology
30%
Dacarbazine
19%
Melanoma
19%
HLA-B7 Antigen
12%
Population
12%
Injection Site Reaction
10%
Drug Evaluation
9%
Genes
9%
Injections
8%
Squamous Cell Carcinoma of Head and Neck
8%
HLA Antigens
7%
Head and Neck Neoplasms
7%
Immunotherapy
6%
Lymph Nodes
5%
Neoplasms
4%
Skin
4%
Lung
4%
Therapeutics
3%
Incidence
3%
Chemical Compounds
Dacarbazine
79%
Refractory
48%
Adjuvant
28%
Dose
17%
Drug
12%